
According to the South Korean team, doctors in China are interested in a partnership and learning more about an experimental drug that it has developed to combat the disease.
The team’s study, titled “Oxidative stress-induced astrocytic collagen biosynthesis drives glial barrier formation and neuronal death in ischemic stroke,” was published online last week in the journal Cell Metabolism.
Advertisement
Ischemic stroke occurs when a blood clot or other blockage obstructs a cerebral blood vessel, cutting off oxygen and nutrients and causing brain cells to die.
Advertisement
Survivors often suffer severe aftereffects, including motor disabilities and cognitive decline. Treatment is further complicated by a narrow three-hour “golden time” window after symptom onset, during which patients must receive emergency care.

Don't Miss:
-
US wraps up military mission in Iraq, giving Baghdad room to strengthen China ties
-
As China and the EU begin crunch trade talks, optimism is in short supply
-
Data centre opposition is growing in Australia. Is there a middle ground?
-
Helper arrested for allegedly slapping 5-year-old boy after he refuses to eat
-
Workers, mostly Indian, building US consulate in Milan agree to record settlement

How Hungary’s richest man funneled millions into Orbán’s propaganda machine
How Real Is the US Withdrawal from the Middle East?
From Iran to China: An Emerging Trans-Central Asian Corridor